Trial Profile
Study MK0767 and metformin in type 2 diabetic patients (0767-020)
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 09 May 2022
Price :
$35
*
At a glance
- Drugs MK 0767 (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors Merck & Co; Merck Sharp & Dohme
- 18 Feb 2014 According to the ClinicalTrials.gov record, status changed to discontinued.
- 23 Oct 2007 New trial record.